Receptors for Targeting Growth Factors for Treatment of Cancers

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Growth factor receptors (GFR)Growth factor receptors (GFR) are expressed on cell membranes or in the cytoplasm and play a major role in cell growth, survival, angiogenesis, and metastasis. Tumor growth and cell survival are composed of dodging apoptotic signals in cancer cells. The growth of cells is further supported by angiogenesis and metastasis to distant organs. Elevated expression of growth factor receptors contributes to the development of drug resistance. Therefore, therapeutics to target GFRs is a potentially attractive molecular approach to treat cancer more effectively. In this review, we have discussed the contribution of growth factor receptors to cancer development and thereby their subsequent molecular targets for novel drugs developed leading to inhibition of growth factor receptor-mediated pathways.

Cite

CITATION STYLE

APA

Jahagirdar, D., Ghodke, S., Mergu, A., Nikam, A., Devarajan, P. V., Jain, R., & Dandekar, P. (2019). Receptors for Targeting Growth Factors for Treatment of Cancers. In AAPS Advances in the Pharmaceutical Sciences Series (Vol. 39, pp. 197–228). Springer Verlag. https://doi.org/10.1007/978-3-030-29168-6_7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free